Pathogen reduction technologies: what are the concerns?
- 22 June 2004
- journal article
- review article
- Published by Wiley in Vox Sanguinis
- Vol. 87 (s2) , 84-89
- https://doi.org/10.1111/j.1741-6892.2004.00459.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Preliminary validation of a new standard of efficacy for stored plateletsTransfusion, 2004
- Radiolabeling of PLTs to assess viability: a proposal for a standardTransfusion, 2004
- FDA approach to evaluation of pathogen reduction technologyTransfusion, 2003
- Transfusion transmission of West Nile virus: a merging of historical and contemporary perspectivesTransfusion, 2003
- Methodologic issues in the use of bleeding as an outcome in transfusion medicine studiesTransfusion, 2003
- Disseminating Innovations in Health CareJAMA, 2003
- Bacterial contamination and transfusion safety: experience in the United StatesTransfusion Clinique et Biologique, 2003
- Pathogen Inactivation in Cellular Blood Components: Clinical Trials and Implications of Introduction to Transfusion MedicineVox Sanguinis, 2002
- Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet componentsSeminars in Hematology, 2001
- In Vitro Assessment of the Quality of Stored Platelet ConcentratesTransfusion Medicine Reviews, 1994